Efficacy and Safety of Adenotonsillectomy for Pediatric Obstructive Sleep Apnea Across Various Age Groups: A Systematic Review.

IF 1.4 Q3 PEDIATRICS
Mohammed Halawani, Arwa Alsharif, Omar Ibrahim Alanazi, Baraa Awad, Abdulaziz Alsharif, Hawazen Alahmadi, Rayan Alqarni, Rahaf Mohammed Alhindi, Abdulmohsen H Alanazi, Abdulmajeed Hassan Alshamrani
{"title":"Efficacy and Safety of Adenotonsillectomy for Pediatric Obstructive Sleep Apnea Across Various Age Groups: A Systematic Review.","authors":"Mohammed Halawani, Arwa Alsharif, Omar Ibrahim Alanazi, Baraa Awad, Abdulaziz Alsharif, Hawazen Alahmadi, Rayan Alqarni, Rahaf Mohammed Alhindi, Abdulmohsen H Alanazi, Abdulmajeed Hassan Alshamrani","doi":"10.3390/pediatric17040071","DOIUrl":null,"url":null,"abstract":"<p><p><b>Objectives</b>: To assess the safety and efficacy of adenotonsillectomy (AT) for treating uncomplicated pediatric obstructive sleep apnea (OSA) in children of different ages. <b>Methods</b>: A systematic search was conducted in four electronic databases, and 71 studies with a total of 9087 participants were included in the analysis. The studies were all before-and-after studies, cohort studies, and randomized controlled trials. Surgical results were analyzed according to age, disease severity, and follow-up duration. <b>Results</b>: Children younger than 7 years at the time of AT had a significantly greater decrease in disease severity, a greater decrease in hypoxemic burden, improved sleep quality, and improved cardiovascular function than children older than 7 years. Both cognitive and behavioral performance improved postoperatively, although these changes were more significantly associated with the duration of follow-up than with age at surgery. Notably, the rate of surgical complications was much greater in children under the age of 3. <b>Conclusions</b>: The current evidence indicates that AT is performed optimally between the ages of 3 and 7 years, offering the greatest chance of disease resolution and remission of associated conditions, balanced with a reduction in surgical risk. We highly recommend conducting high-quality randomized controlled trials to further inform the clinical guidelines for pediatric AT.</p>","PeriodicalId":45251,"journal":{"name":"Pediatric Reports","volume":"17 4","pages":""},"PeriodicalIF":1.4000,"publicationDate":"2025-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12286109/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pediatric Reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3390/pediatric17040071","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PEDIATRICS","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: To assess the safety and efficacy of adenotonsillectomy (AT) for treating uncomplicated pediatric obstructive sleep apnea (OSA) in children of different ages. Methods: A systematic search was conducted in four electronic databases, and 71 studies with a total of 9087 participants were included in the analysis. The studies were all before-and-after studies, cohort studies, and randomized controlled trials. Surgical results were analyzed according to age, disease severity, and follow-up duration. Results: Children younger than 7 years at the time of AT had a significantly greater decrease in disease severity, a greater decrease in hypoxemic burden, improved sleep quality, and improved cardiovascular function than children older than 7 years. Both cognitive and behavioral performance improved postoperatively, although these changes were more significantly associated with the duration of follow-up than with age at surgery. Notably, the rate of surgical complications was much greater in children under the age of 3. Conclusions: The current evidence indicates that AT is performed optimally between the ages of 3 and 7 years, offering the greatest chance of disease resolution and remission of associated conditions, balanced with a reduction in surgical risk. We highly recommend conducting high-quality randomized controlled trials to further inform the clinical guidelines for pediatric AT.

Abstract Image

Abstract Image

腺扁桃体切除术治疗不同年龄组儿童阻塞性睡眠呼吸暂停的疗效和安全性:一项系统综述。
目的:评价腺扁桃体切除术(AT)治疗不同年龄儿童无并发症的儿童阻塞性睡眠呼吸暂停(OSA)的安全性和有效性。方法:系统检索4个电子数据库,纳入71项研究,共9087名受试者。这些研究都是前后对照研究、队列研究和随机对照试验。根据年龄、病情严重程度和随访时间对手术结果进行分析。结果:与7岁以上的儿童相比,at时年龄小于7岁的儿童疾病严重程度的下降幅度更大,低氧血症负担的下降幅度更大,睡眠质量得到改善,心血管功能得到改善。术后认知和行为表现均有改善,尽管这些变化与随访时间的关系比与手术年龄的关系更为显著。值得注意的是,3岁以下儿童的手术并发症发生率要高得多。结论:目前的证据表明,AT在3至7岁之间进行最佳,提供了最大的疾病解决和相关疾病缓解的机会,平衡了手术风险的降低。我们强烈建议进行高质量的随机对照试验,以进一步为儿科AT的临床指南提供信息。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Pediatric Reports
Pediatric Reports PEDIATRICS-
CiteScore
2.10
自引率
0.00%
发文量
55
审稿时长
11 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信